Prevents and repairs actinic injuries.

Specially formulated for actinic keratosis (AK) and other forms of non-melanoma skin cancer (NMSC), for prevention and adjuvant treatment. For patients undergoing pharmacological therapy or surgery for AK or other forms of NMSC, treatment with Eryfotona AK-NMSC should be started as soon as the lesions are closed. Medical device. Carefully read the instructions for use on the labeling and leaflet.

Apply a generous amount to the affected area twice a day, in the morning and at midday, as photolyase is activated by visible light. Avoid contact with eyes and mucous membranes, there is no data regarding the use of Eryfotona AK-NMSC in children, pregnant or lactating women.
Shake before use.

Reduces and improves the field of cancerization associated with actinic keratosis (AK) and non-melanoma skin cancer (NMSC). Creates a protective film on the skin, which prevents the appearance of new lesions and promotes the repair of existing lesions.

Repairsomes® (UVB-UVA Filter complex+ plankton extract), Bisabolol, Tocopheryl acetate, Panthenol, Excipients qs.